2022 - Research.com Best Scientist Award
1998 - Fellow of the American Association for the Advancement of Science (AAAS)
1987 - Member of the National Academy of Sciences
Bernard Moss mainly investigates Virology, Virus, Vaccinia, Molecular biology and Orthopoxvirus. His Virology study incorporates themes from Recombinant virus, Recombinant DNA, Immunology and Cytotoxic T cell, CTL*. His Virus research integrates issues from Expression vector and Modified vaccinia Ankara.
His Vaccinia research incorporates elements of Cell culture, Neutralizing antibody, Vector, Immunity and Vaccination. In his study, DNA is inextricably linked to Gene, which falls within the broad field of Molecular biology. His research in Orthopoxvirus tackles topics such as Poxviridae which are related to areas like Chordopoxvirinae, Extracellular, Thymidine kinase and Microbiology.
Virology, Virus, Molecular biology, Vaccinia and Orthopoxvirus are his primary areas of study. Bernard Moss has included themes like Recombinant virus, Recombinant DNA, Antibody, Immunology and Cytotoxic T cell in his Virology study. The Virus study combines topics in areas such as Mutant and Vaccination.
His work carried out in the field of Molecular biology brings together such families of science as RNA, Biochemistry, DNA, Messenger RNA and Gene. His biological study spans a wide range of topics, including Neutralizing antibody, Vector, Expression vector, Immunogenicity and Cell biology. Bernard Moss focuses mostly in the field of Orthopoxvirus, narrowing it down to matters related to Poxviridae and, in some cases, Chordopoxvirinae.
His primary areas of investigation include Virology, Virus, Vaccinia, Cell biology and Viral replication. The various areas that he examines in his Virology study include Antibody, Immunology, Immunogenicity and Modified vaccinia Ankara. His Virus research is multidisciplinary, relying on both Molecular biology, Orthopoxvirus, Mutant and Monkeypox virus.
Bernard Moss interconnects Reporter gene, Membrane protein and Viroplasm in the investigation of issues within Molecular biology. In his study, which falls under the umbrella issue of Vaccinia, Transfection is strongly linked to Vector. His Cell biology research also works with subjects such as
The scientist’s investigation covers issues in Virology, Virus, Vaccinia, Immunology and Modified vaccinia Ankara. His research integrates issues of Cellular immunity and Viral vector, Recombinant DNA in his study of Virology. Bernard Moss combines subjects such as Molecular biology, Orthopoxvirus, Mutant and Monkeypox virus with his study of Virus.
The concepts of his Molecular biology study are interwoven with issues in RNase P, RNA silencing and Messenger RNA. His Vaccinia research incorporates themes from Viral entry, Cell culture, Virus Cultivation and Cell biology. His research in Immunology intersects with topics in HIV vaccine and Heterologous.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase
T R Fuerst;E G Niles;F W Studier;B Moss.
Proceedings of the National Academy of Sciences of the United States of America (1986)
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.
Rama Rao Amara;Francois Villinger;John D. Altman;Shari L. Lydy.
Science (2001)
Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques.
S Chakrabarti;K Brechling;B Moss.
Molecular and Cellular Biology (1985)
HIV-specific cytotoxic T lymphocytes in seropositive individuals.
Bruce D. Walker;Sekhar Chakrabarti;Bernard Moss;Timothy J. Paradis.
Nature (1987)
Vaccinia virus: a selectable eukaryotic cloning and expression vector
Michael Mackett;Geoffrey L. Smith;Bernard Moss.
Proceedings of the National Academy of Sciences of the United States of America (1982)
In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.
R L Willey;D H Smith;L A Lasky;T S Theodore.
Journal of Virology (1988)
General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.
M Mackett;G L Smith;B Moss.
Journal of Virology (1984)
Nonreplicating vaccinia vector efficiently expresses recombinant genes
Gerd Sutter;Bernard Moss.
Proceedings of the National Academy of Sciences of the United States of America (1992)
Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety
Bernard Moss.
Proceedings of the National Academy of Sciences of the United States of America (1996)
Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein.
Jeffrey D. Lifson;Jeffrey D. Lifson;Mark B. Feinberg;Gregory R. Reyes;Linda Rabin.
Nature (1986)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Institutes of Health
National Institutes of Health
Emory University
Duke University
Emory University
University of Cambridge
National Institutes of Health
National Institutes of Health
Emory University
Children's Hospital of Philadelphia
University of Trento
Georgia Institute of Technology
University of Pennsylvania
University of Illinois at Urbana-Champaign
Tsinghua University
Northeast Normal University
Jiangnan University
University of Western Australia
University of Liverpool
Inserm : Institut national de la santé et de la recherche médicale
University of Florence
Harvard University
University of Lyon System
University of Franche-Comté
Colorado State University
University of Scranton